In addition, although with somewhat mixed results (37), recent observational studies suggest a potential association between antipsychotic-induced hyperprolactinemia and an increased risk of occurrence of breast cancer, which led to some authors to recommend monitoring prolactin concentrations and avoiding the use of prolactin-elevating antipsychotics in women (38, 39). This evidence concerns the gene PRL and breast cancer.